Pharma 4.0 Continuous mRNA Drug Products Manufacturing

Pharma 4.0 Continuous mRNA Drug Products Manufacturing

Continuous mRNA drugs manufacturing is perceived to nurture flow processes featuring quality by design, controlled automation, real time validation, robustness, and reproducibility, pertaining to regulatory harmonization. However, the actual adaptation of the latter remains elusive, hence batch-to-c...

Full description

Bibliographic Details
Main Authors: Andreas Ouranidis, Christina Davidopoulou, Reald-Konstantinos Tashi, Kyriakos Kachrimanis
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceutics
Subjects:
systems-based
pharma 4.0
digital design
continuous mRNA manufacturing
RNA vaccines
continuous RNA vaccine manufacturing
Online Access:https://www.mdpi.com/1999-4923/13/9/1371

Internet

https://www.mdpi.com/1999-4923/13/9/1371

Similar Items